CARRATU', Pierluigi
 Distribuzione geografica
Continente #
NA - Nord America 9.473
AS - Asia 3.869
EU - Europa 2.478
SA - Sud America 997
AF - Africa 146
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.977
Nazione #
US - Stati Uniti d'America 9.358
SG - Singapore 1.644
CN - Cina 922
BR - Brasile 799
HK - Hong Kong 491
SE - Svezia 466
DE - Germania 358
RU - Federazione Russa 330
IT - Italia 257
UA - Ucraina 251
FI - Finlandia 240
FR - Francia 211
VN - Vietnam 209
GB - Regno Unito 181
IN - India 127
AR - Argentina 69
BD - Bangladesh 66
IQ - Iraq 61
ID - Indonesia 56
CA - Canada 43
MX - Messico 43
TR - Turchia 43
ZA - Sudafrica 36
EC - Ecuador 34
JP - Giappone 33
IE - Irlanda 31
UZ - Uzbekistan 31
CO - Colombia 29
VE - Venezuela 29
SA - Arabia Saudita 26
ES - Italia 25
PK - Pakistan 25
BE - Belgio 24
CI - Costa d'Avorio 23
PL - Polonia 21
MA - Marocco 20
CZ - Repubblica Ceca 19
NL - Olanda 17
PH - Filippine 17
AT - Austria 15
MY - Malesia 15
EG - Egitto 14
TN - Tunisia 14
AE - Emirati Arabi Uniti 13
KE - Kenya 12
NP - Nepal 11
PY - Paraguay 11
PE - Perù 10
DZ - Algeria 9
JO - Giordania 9
AU - Australia 7
IL - Israele 7
JM - Giamaica 7
LB - Libano 7
AZ - Azerbaigian 6
IR - Iran 6
BH - Bahrain 5
BO - Bolivia 5
CL - Cile 5
CR - Costa Rica 5
ET - Etiopia 5
KZ - Kazakistan 5
LT - Lituania 5
OM - Oman 5
PA - Panama 5
UY - Uruguay 5
CH - Svizzera 4
NG - Nigeria 4
PS - Palestinian Territory 4
TW - Taiwan 4
AL - Albania 3
EU - Europa 3
GE - Georgia 3
HN - Honduras 3
KG - Kirghizistan 3
QA - Qatar 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
GR - Grecia 2
KR - Corea 2
ML - Mali 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
RO - Romania 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GI - Gibilterra 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
Totale 16.963
Città #
Fairfield 1.013
Ashburn 891
Woodbridge 861
Singapore 854
Chandler 831
Jacksonville 570
Houston 552
Hong Kong 491
Seattle 429
San Jose 382
Nyköping 362
Ann Arbor 352
Cambridge 347
Wilmington 313
Beijing 238
Roxbury 175
Lawrence 174
Nanjing 172
Lauterbourg 156
Dearborn 142
Des Moines 114
Helsinki 94
Los Angeles 94
Boardman 90
New York 90
Dallas 80
São Paulo 74
Brooklyn 66
Ho Chi Minh City 60
Bari 58
Santa Clara 56
San Diego 51
Princeton 46
Buffalo 45
Hebei 44
Munich 42
Council Bluffs 40
Hanoi 40
London 39
Shenyang 39
Inglewood 36
Jiaxing 35
Jakarta 33
Dublin 31
Tokyo 31
Rio de Janeiro 29
Dong Ket 28
Nanchang 28
Orem 25
Brussels 24
Chicago 24
Abidjan 23
Hefei 23
Changsha 22
Tashkent 22
Atlanta 21
Baghdad 21
Johannesburg 20
Turi 20
Belo Horizonte 19
Frankfurt am Main 19
Moscow 19
Taranto 19
Paris 18
Guangzhou 17
Pune 17
Warsaw 17
Curitiba 16
Kunming 16
Tianjin 16
Denver 15
Mexico City 15
Olomouc 15
Phoenix 15
Toronto 15
Dhaka 14
Jinan 14
Nuremberg 14
Redwood City 14
Stockholm 14
Brasília 13
Mottola 13
New Delhi 13
Guayaquil 12
Istanbul 12
Salvador 12
Boston 11
Chennai 11
Haiphong 11
Montreal 11
Porto Alegre 11
Washington 11
Campinas 10
Falkenstein 10
Goiânia 10
Jeddah 10
Nairobi 10
Norwalk 10
Recife 10
Turku 10
Totale 11.622
Nome #
An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls 256
Voluntary lung function screening to reveal new COPD cases in southern Italy 250
Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea 212
Analysis of aortic remodeling and stiffness in patients with obstructive sleep apnea syndrome: Preliminary results 191
An Electronic Nose Discriminates between the Exhaled Breath of Patients with Pleural Malignant Mesothelioma and Healthy Controls, 181
Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD 176
An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea 172
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 169
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 160
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 159
And the patient said: Let me be able to breathe and dream 158
Enviromental Asbestos Exposure as a Risk Factor for Small Airways Obstruction 157
Evaluation of endothelial function and cardiovascular risk in non-obese patients with slight degree of obstructive sleep apnea syndrome 156
A case of cryptogenic organizing pneumonia occurring in Crohn's disease 150
Correlations between severity of obstructive sleep apnoea and systolic pulmonary artery pressure: preliminary results 149
Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose 148
Ovarian cycle may influence the exhaled volatile organic compounds profile analyzed by an electronic nose 144
Obstructive Sleep Apnea, Hypertension, and Their Additive Effects on Atherosclerosis 144
Atrial flutter regression in HIV-associated pulmonary arterial hypertension after treatment with bosentan 139
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 139
Does Nocturnal Hypoventilation Have a Protective Effect on Cardiovascular Comorbidity in Obesity Hypoventilation Syndrome? 137
The role of education in the self-compilation of Epworth sleepiness scale questionnaire in patients with suspected obstructive sleep apnea 137
Enviromental asbestos exposure as a risk factor for small airways obstruction 136
An electronic nose may sniff out amyotrophic lateral sclerosis 135
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 134
A new approach for the assessment of sleepiness and predictivity of obstructive sleep apnea in drivers: A pilot study 134
Nocturnal Hypoventilation May Have a Protective Effect on Ischemic Heart Disease in Patients with Obesity Hypoventilation Syndrome 133
A Portable Device as Sleep-Screening Tool in the Identification of Obstructive Sleep Apnea in Chronic Heart Failure: Which Value Should We Consider as Cutoff? 132
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD 130
Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial 130
In vitro identification of new transcriptomic and miRNomic profiles associated with pulmonary fibrosis induced by high doses everolimus: Looking for new pathogenetic markers and therapeutic targets 129
An electronic nose distinguishes the exhaled breath of obese patients with obstructive sleep apnoea (OSA) from subjects with a similar body mass index and without OSA 127
Using PaCO2 values to grade obesity-hypoventilation syndrome severity: a retrospective study 126
Exhaled breath profiling in patients with COPD and OSA overlap syndrome: A pilot study 125
Acute parenchymal lung involvement in a 68-year-old woman with systemic lupus erythematosus, anemia, and thrombocytopenia 125
Alterazioni del metabolismo dell'endotelina-1 in pazienti con tromboembolia polmonare 123
A60 antigen, as a new tuberculin 122
Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma 121
TITRATION EFFECTIVENESS OF TWO AUTOCPAP DEVICES DRIVEN BY DIFFERENT ALGORITHMS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA 119
Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: Preliminary results. 119
Lack of association between OSAS and Hypothyroidism 119
An electronic nose discriminates exhaled breath of patients with untreated Pulmonary Sarcoidosis from controls 119
Bilateral diaphragmatic paralysis after kidney surgery 119
Endogenous heme oxygenase prevents impairment of cerebral vascular functions caused by seizures 118
Smoking Habit in Severe Obese after bariatric procedures. 118
The Prognostic Role of Obstructive Sleep Apnea at the Onset of Amyotrophic Lateral Sclerosis 117
Electronic Nose Technology in Respiratory Diseases 113
Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome? 112
24-hours Endothelin-1 urinary excretion in patients with Interstitial Lung Disease 111
Increased IL-6 and IL-4 in exhaled breath condensate of patients with nasal polyposis 111
Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease 111
Predictive equations for CPAP titration in OSAS patients 110
Severe obstructive sleep apnoea exacerbates the microvascular impairment in very mild hypertensives 110
Epileptic seizures cause extended postictal cerebral vascular dysfunction that is prevented by HO-1 overexpression 110
Is there a correlation between OSAS duration/severity and carotid intima-media thickness? 110
Increased 24-hour endothelin-1 urinary excretion in patients with chronic obstructive pulmonary disease. 108
Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS) 108
Home Unattended Portable Monitoring and AutoCPAP Titration In Patients With High Risk for Moderate to Severe OSA. 106
Abnormalities of Endothelin-1 metabolism in Pulmonary Embolism 106
Sniff Nasal Pressure Is a Sensitive Marker of Poor Outcome in Amyotrophic Lateral Sclerosis 106
HIGH DOSES OF M-TOR INHIBITORS MAY INDUCE PULMONARY PRO-FIBROTIC EFFECTS IN RENAL TRANSPLANT RECIPIENTS: RESULT OF A TRANSLATIONAL COMPARATIVE RESEARCH APPROACH BETWEEN PROGRAF VERSUS EVEROLIMUS 106
Efficacy of positional therapy in treatment of patients with obstructive sleep apnea: a pilot study 106
Clinical variability of respiratory pulmonary hypertension: implications for diagnosis and management 104
EVEROLIMUS-INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION IN BRONCHIAL AND PULMONARY CELLS: WHEN THE DOSAGE DOES MATTER IN TRANSPLANTATION 103
Effect of zafirlukast on methacholine and ultrasonically nebulized distilled water challenge in patients with mild asthma. 101
Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients 101
An electronic nose in the diagnostic assessment of asthma in pediatric patients 100
Role of plasmatic leptin in response to hypercapnia in obese patients with or without osas 100
Evaluation of a transcutaneous carbon dioxide monitor in severe obesity 99
Hyperventilation In Patients With Pulmonary Arterial Hypertension Is Related To Increased Chemosensitivity 99
Correlation between pulse transit time and microvascular impairment in OSAS patients 99
Excessive daytime sleepiness in women without OSA 98
Zafirlukast single oral dose pre-treatment prevents FEV1 drop after bronchial challenge in mild asthma 98
Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency 97
CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis 96
Heme oxygenase inhibition reduces neuronal activation evoked by bicuculline in newborn pigs. 96
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? 96
Incidence of deep venous thrombosis in patients with both pulmonary embolism and copd 96
End points for pulmonary arterial hypertension: a way backward. 95
Exhaled Volatile Organic Compounds analysis by e-nose can detect Idiopathic Pulmonary Fibrosis 95
Is there a correlation between OSAS duration/severity and carotid intima-media thickness? 91
Long-term evaluation of mental fatigue by Maastricht Questionnaire in patients with OSAS treated with CPAP 90
Interleukin-8 and soluble intercellular adhesion molecule 1 during acute respiratory distress syndrome and in response to prolonged methylprednisolone treatment 89
Influence of obstructive sleep apnea on endothelial function in obese patients. 89
Endogenous heme oxygenase prevents impairment of cerebral vascular functions caused by seizures. 89
Lower SNIP value is correlated to the need of intubation in Amyotrophic Lateral Sclerosis 88
ET-1 induces mitogenesis in ovine airway smooth muscle cells via ETA and ETB receptors. 88
Exhaled breath condensate as matrix for toluene detection: a preliminary study 87
Use of the exhaled breath condensate in the study of airway inflammation after hypertonic saline challenge 87
HPV16 E7-dependent transformation activates NHE1 through a PKA-RhoA-induced inhibition of p38alpha 87
Assessment of eosinophilic nasal inflammation in patients with severe asthma and nasal polyposis before and after six months of therapy with Benralizumab 86
Aumento dell'escrezione urinaria di Endotelina-1 in pazienti affetti da BPCO 85
Correlation between sniff nasal inspiratory pressure (snip) and amyotrophic lateral sclerosis functional rating scale (alsfrs) in als patients 85
Failure of noninvasive ventilation during hypercapnic exacerbation of chronic obstructive pulmonary disease: the role of chronic kidney diseases 85
Cerebral heme-heme oxygenase-carbon monoxide-bilirubin system protects cerebral microvessels during seizures 84
Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS. 84
Endogenous Endothelin-1 production/excretion in patients with COPD 83
La presenza di apnea notturna peggiora il danno microcircolatorio sin dalle prime fasi dell'ipertensione arteriosa 83
Disfunzione endoteliale nella malattia vascolare polmonare ipossica 83
Noninvasive ventilation (NIV) in the management of chronic heart failure (CHF) 81
Totale 11.935
Categoria #
all - tutte 71.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.223


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021407 0 0 0 0 0 0 0 0 0 230 94 83
2021/20221.136 32 134 5 89 49 76 40 67 75 56 170 343
2022/20231.952 266 185 120 204 259 300 17 197 337 8 26 33
2023/2024610 51 124 38 43 67 136 37 31 4 19 4 56
2024/20252.629 41 33 246 75 48 212 177 245 132 123 410 887
2025/20264.662 812 257 268 553 626 295 634 155 594 468 0 0
Totale 17.301